Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Children´s Clinic, Randers
When children with asthma are treated with inhaled corticosteroids there is a risk of systemic adverse events such as growth suppression. It has been reported that treatment with budesonide 200 microgram per day does not affect short term growth in children with asthma. The aim of the present study is to assess if an unaffected short term growth means that also long term growth will be unaffected.
Short and long term growth in asthmatic children treated with budesonide will be compared with the growth in asthmatic children treated with montelukast.
Age
6–11
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
age 6-11,
prepubertal,
asthma,
normal weight and height,
informed consent
You may not be if
treatment with systemic/inhaled/intranasal corticosteroids within the last week,